The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Is The Artificial Organs And Bionic Implants Market’s Market Value Anticipated To Evolve From 2026 To 2030?
The artificial organs and bionic implants market has experienced robust growth in recent years. It is projected to increase from $48.75 billion in 2025 to $52.76 billion in 2026, showing a compound annual growth rate (CAGR) of 8.2%. During the historic period, this expansion can be attributed to the limited availability of artificial organs, a reliance on mechanical bionics, the high cost associated with early bionic implants, low adoption rates due to insufficient awareness, and a dependence on hospital-based implant procedures.
The artificial organs and bionic implants market size is anticipated to experience robust growth in the coming years. It is projected to reach $71.53 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.9%. This growth throughout the forecast period can be ascribed to advancements in electronic bionics and neural interfaces, increased research in regenerative medicine, a growing geriatric population and the prevalence of chronic diseases, the expansion of ambulatory surgical centers, and rising government support and funding for medical device innovation. Major trends during this period include the increased adoption of advanced prosthetics and bionic limbs, the greater integration of neural implants and sensory devices, an escalating demand for artificial organs due to shortages, an emphasis on personalized and patient-specific implants, and improved post-surgical rehabilitation and support technologies.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20487&type=smp
Which Core Factors Are Supporting The Expansion Of The Artificial Organs And Bionic Implants Market?
The rising frequency of organ transplantation is projected to boost the expansion of the artificial organs and bionic implants market in the coming years. This medical intervention involves surgically placing a healthy donor organ into a patient whose original organ is compromised, impaired, or no longer functioning. This growth in transplants stems from a higher occurrence of chronic illnesses and organ malfunctions, coupled with progress in medical technology and surgical methods. Artificial organs and bionic implants support the process of organ transplantation by offering interim remedies, shortening waiting periods, enhancing patient results, and serving as substitutes when donor organs are not accessible. For example, as reported in January 2025 by the Organ Procurement and Transplantation Network, a US-based non-profit body, over 48,000 organ transplants were conducted in 2024, marking a 3.3 percent rise compared to 2023. Consequently, the expanding occurrence of organ transplants is a key factor propelling the artificial organs and bionic implants market’s expansion.
How Are Different Segment Groups Identified Within The Artificial Organs And Bionic Implants Market?
The artificial organs and bionic implants market covered in this report is segmented –
1) By Product: Artificial Organs, Artificial Bionics
2) By Technology: Mechanical Bionics, Electronic Bionics
3) By End User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Artificial Organs: Artificial Heart, Artificial Kidney, Artificial Liver, Artificial Pancreas, Artificial Lungs
2) By Artificial Bionics: Bionic Limbs, Bionic Eyes, Bionic Ears, Neural Implants, Bionic Skin
Which Trends Are Contributing To Changes In The Artificial Organs And Bionic Implants Market?
Major companies engaged in the artificial organs and bionic implants market are prioritizing the creation of highly advanced solutions, including brain implant technology systems, aimed at enhancing cognitive capabilities and addressing neurological conditions. These brain implant technology systems incorporate devices that establish an interface with the brain to monitor, stimulate, or modify neural activity for therapeutic purposes, neuroprosthetics, or research. For example, in May 2023, Neuralink Corp., a US-based neurotechnology company, secured Food and Drug Administration (FDA) approval to initiate its first human clinical trials for its brain implant technology. This innovation seeks to enable individuals with severe paralysis to regain the capacity to communicate with and manipulate external devices solely through their thoughts. This approval represents a substantial milestone for the company, which had previously encountered difficulties, including an earlier rejection due to safety concerns. The trial will evaluate the device’s effectiveness in interpreting neural signals and transmitting them via Bluetooth to control computers and mobile devices, potentially offering assistance to those with conditions such as amyotrophic lateral sclerosis (ALS).
Who Are The Companies Shaping The Artificial Organs And Bionic Implants Market Landscape?
Major companies operating in the artificial organs and bionic implants market are Medtronic plc, Asahi Kasei Medical Co. Ltd., B. Braun Melsungen AG, Terumo Medical Corp., Edwards Lifesciences Corporation, Ottobock SE and Co. KGaA, Cochlear Limited, Ossur hf., Thoratec Corporation, Berlin Heart GmbH, Jarvik Heart Inc., SynCardia Systems LLC, BiVACOR Inc., Gambro AB, Pixium Vision, ALVI Labs, WillowWood Global LLC, Nano Retina Inc., Organovo Holdings Inc., Abbott Laboratories, ABIOMED Inc., Ekso Bionics Holdings Inc., ReWalk Robotics Ltd, LivaNova PLC, Second Sight Medical Products Inc.
Access The Complete Artificial Organs And Bionic Implants Market Report:
Which Region Is The Dominant Market In The Artificial Organs And Bionic Implants Market?
North America was the largest region in the artificial organs and bionic implants market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial organs and bionic implants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Artificial Organs And Bionic Implants Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=20487&type=smp
Browse Through More Reports Similar to the Global Artificial Organs And Bionic Implants Market 2026, By The Business Research Company
Artificial Organ And Bionics Market Report 2026
https://www.thebusinessresearchcompany.com/report/artificial-organ-and-bionics-global-market-report
Spine Implants Market 2026
https://www.thebusinessresearchcompany.com/report/spine-implants-market
Breast Implants Market Report 2026
https://www.thebusinessresearchcompany.com/report/breast-implants-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model